To investigate whether programmed death-ligand 1 (PD-L1) is overexpressed or underexpressed in NSCLC, Western blotting was employed to examine PD-L1 levels in all types of cells referred as before. This evidence concerns the gene CD274 and non-small cell lung carcinoma.